Intellia Therapeutics collects $15 mln

Intellia Therapeutics has received $15 million in Series A financing. Atlas Venture and Novartis led the round. Intellia develops therapeutic products for gene editing and repair.

18 November 2014•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail